Elena P. Tikhonova
Krasnoyarsk, KYA 660022, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of riamilovir in the treatment of COVID-19
Journal: Terapevticheskii arkhiv
Published: May 29, 2024
Association of Blood NK Cell Phenotype with the Severity of Liver Fibrosis in Patients with Chronic Viral Hepatitis C with Genotype 1 or 3.
Journal: Diagnostics (Basel, Switzerland)
Published: January 18, 2024
The impact of BMI on the course of the acute SARS-COV-2 infection and the risks that emerge during the first year after the hospital discharge. Subanalysis evidence of the AKTIV and AKTIV 2 registries
Journal: Problemy endokrinologii
Published: January 19, 2023
Pharmacoepidemiological research of COVID-19 in the Russian Federation EGIDA-2020
Journal: Terapevticheskii arkhiv
Published: January 26, 2022
Structure- and Interaction-Based Design of Anti-SARS-CoV-2 Aptamers.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: December 16, 2021
Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»).
Journal: Kardiologiia
Published: May 12, 2021
Experience of olokizumab use in COVID-19 patients
Journal: Terapevticheskii arkhiv
Published: February 07, 2021
International register "Analysis of Chronic Non-infectious Diseases Dynamics After COVID-19 Infection in Adult Patients (ACTIV SARS-CoV-2)"
Journal: Kardiologiia
Published: January 11, 2021
The activity of enzymes in lymphocytes of children and adults with chronic viral hepatitis B and C
Journal: Klinicheskaia laboratornaia diagnostika
Published: December 26, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026